Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
11.55%
operating margin TTM
13.16%
revenue TTM
251.97 Million
revenue per share TTM
4.95$
valuation ratios | |
|---|---|
| pe ratio | 16.94 |
| peg ratio | -0.38 |
| price to book ratio | 3.34 |
| price to sales ratio | 2.00 |
| enterprise value multiple | 10.36 |
| price fair value | 3.34 |
profitability ratios | |
|---|---|
| gross profit margin | 74.83% |
| operating profit margin | 13.16% |
| pretax profit margin | 13.48% |
| net profit margin | 11.55% |
| return on assets | 13.86% |
| return on equity | 20.85% |
| return on capital employed | 21.3% |
liquidity ratios | |
|---|---|
| current ratio | 2.91 |
| quick ratio | 2.64 |
| cash ratio | 0.73 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 83.56 |
| operating cycle | 137.32 |
| days of payables outstanding | 19.47 |
| cash conversion cycle | 117.85 |
| receivables turnover | 6.79 |
| payables turnover | 18.74 |
| inventory turnover | 4.37 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.03 |
| interest coverage | 8.65 |
| cash flow to debt ratio | 8.54 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.81 |
| cash per share | 1.84 |
| operating cash flow per share | 0.81 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 8.54 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 4,114.80 |
Frequently Asked Questions
When was the last time Puma Biotechnology, Inc. (NASDAQ:PBYI) reported earnings?
Puma Biotechnology, Inc. (PBYI) published its most recent earnings results on 06-08-2026.
What is Puma Biotechnology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Puma Biotechnology, Inc. (NASDAQ:PBYI)'s trailing twelve months ROE is 20.85%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Puma Biotechnology, Inc. (PBYI) currently has a ROA of 13.86%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PBYI's net profit margin stand at?
PBYI reported a profit margin of 11.55% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PBYI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.91 in the most recent quarter. The quick ratio stood at 2.64, with a Debt/Eq ratio of 0.03.